Daiwa Securities Group
IGMS

Daiwa Securities Group’s IGM Biosciences IGMS Stock Holding History

Daiwa Securities Group’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-88
Closed -$1K – 1352
2023
Q3 		$1K Hold
88
– – ﹤0.01% 1256
2023
Q2 		$1K Hold
88
– – ﹤0.01% 1277
2023
Q1 		$1K Hold
88
– – ﹤0.01% 1255
2022
Q4 		$1K Hold
88
– – ﹤0.01% 1273
2022
Q3 		$2K Hold
88
– – ﹤0.01% 1230
2022
Q2 		$2K Hold
88
– – ﹤0.01% 1240
2022
Q1 		$2K Hold
88
– – ﹤0.01% 1252
2021
Q4 		$3K Hold
88
– – ﹤0.01% 1243
2021
Q3 		$6K Buy
88
+42
+91% +$3.21K ﹤0.01% 1168
2021
Q2 		$4K Hold
46
– – ﹤0.01% 1088
2021
Q1 		$4K Hold
46
– – ﹤0.01% 1089
2020
Q4 		$4K Buy
+46
New +$3.23K ﹤0.01% 1069

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Daiwa Securities Group's IGMS Position: Q4 2023 in Review

Daiwa Securities Group sold out of IGM Biosciences (IGMS) in Q4 2023, closing a stake of 88 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in IGMS in Q4 2020 and held it in 12 quarters. The position peaked at $6K in Q3 2021. 72 funds tracked by Wall St. Rank hold IGMS as of Q4 2023.

  • Daiwa Securities Group reported no remaining IGM Biosciences position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 88 IGM Biosciences shares in Q4 2023, an estimated $1K.
  • Daiwa Securities Group first reported a position in IGM Biosciences in Q4 2020 and held it in 12 quarters.
  • Daiwa Securities Group's IGM Biosciences position peaked at $6K in Q3 2021.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.